Proposal of regulatory framework for Advanced Therapy Medicinal Products in Brazil
DOI:
https://doi.org/10.22239/2317-269X.01078Keywords:
Regulamentação, Centro de Processamento Celular, Produtos de Terapias Avançadas, Terapia Celular, Marco RegulatórioAbstract
Introduction: Advanced Therapy Medicinal Products (ATMP) have been a therapeutic promise for the treatment of several diseases, including those for which there is no therapeutic alternative available on the market. These products, obtained from human cells, were categorized internationally as a new therapeutic class with similar approach as biological medicines, although with different criteria, due to their peculiarities. Objective: This article aims to describe the history of the discussions and regulations published for the thematic, and to present the perspectives related to the development of the Brazilian regulatory framework for this new category of product, with the objective of providing a stable and transparent regulatory environment, favorable to the technological development at national level, as well as to attract national and international investments in the field. Method: The development of this article was based on the research of the history of normative published about the topic, on the regulatory initiatives implemented by Anvisa as well as on the participation of the authors in forums and discussions towards the theme. Results: Basis of the national regulatory framework for PTA to be elaborated, and exposure of the main aspects of the proposal. Conclusions: The proposal of regulatory framework for ATMP will cover the regulations for evaluation and approval of clinical trials by Anvisa, Certification of Good Cell Practices for producer establishments and marketing authorization of products.Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Health Surveillance under Debate: Society, Science & Technology (Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnología) – “Visa em Debate”
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.
